CD80 and neoplasm: Studies have shown that the addition of the costimulatory molecules CD80 or 4-1BBL to CAR19-BBζ or CAR19-28z T cells, respectively, enhanced CAR T-cell persistence and tumor clearance in a mouse model of ALL (79).